Pfluger proposes bipartisan Biosimilar Red Tape Elimination Act
A bipartisan bill sponsored on Sept. 19 by U.S. Rep. August Pfluger (R-TX) aims to improve patient access to lower-cost prescription medications and increase competition in the biological drug market. The Biosimilar Red Tape Elimination Act, H.R. 5526, which is Read more…
